Day One Biopharmaceuticals I

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$21.44

+0.05 (+0.23%)

As of Mar 22, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 88%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +162.5% upside

Low Target $41.40

Average Target $56.28

High Target $65.73

Current Price $21.44

Current
$21.44

Target
$56.28

$41.40 $56.28 avg $65.73

Scenario Analysis

Bear Case

$41.40

93.1%

Low target

Base Case

$56.28

+162.5%

Avg target

Bull Case

$65.73

+206.6%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$13.20

62.4% from high

52-Week Low

$5.64

+280.5% from low

Target vs 52W High

$56.28

+326.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%